These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3915576)

  • 61. [Arterial hypertension in the elderly. Is there still room for diuretics?].
    Dubois D; Gauchat M; Guelpa G
    Praxis (Bern 1994); 1996 Jan; 85(5):117-25. PubMed ID: 8643905
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Xipamide: no advantage over bendrofluazide in hypertension.
    Ramsay LE; Freestone S
    Br J Clin Pharmacol; 1984 Oct; 18(4):616-8. PubMed ID: 6487502
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A multicentre open trial indapamide in general practice.
    Bowker CH; Murphy MA
    Postgrad Med J; 1981; 57 Suppl 2():53-6. PubMed ID: 7033948
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical evaluation of SE 1520 in the treatment of hypertension.
    Seedat YK; Reddy J
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):275-80. PubMed ID: 4208341
    [No Abstract]   [Full Text] [Related]  

  • 65. [Controlled study of antihypertensive effects of indapamide and metoprolol and their combination in patients with essential arterial hypertension].
    Novo S; Licata G; Pinto A; Davì G; Pepe S; Di Vitale P; Mannino V; Strano A
    Cardiologia; 1982; 27(8):765-88. PubMed ID: 6765445
    [No Abstract]   [Full Text] [Related]  

  • 66. [Effect of diuretics on serum lipids in hypertension].
    Tikhonov VP; Umurzakov EU
    Sov Med; 1986; (2):21-5. PubMed ID: 3704758
    [No Abstract]   [Full Text] [Related]  

  • 67. [Etozolin in the treatment of essential arterial hypertension of mild-to-moderate degree].
    Salerno L; Pepe S; Salli L; Curiale B; Agnello C; Ferraro A
    Minerva Cardioangiol; 1988; 36(1-2):43-8. PubMed ID: 3386853
    [No Abstract]   [Full Text] [Related]  

  • 68. ["Slow-release" metoprolol in the therapy of hypertension: comparison with divided doses].
    Pirani R; Buzzetti G; Gruppillo P; Padovan G; Masoni C
    Clin Ter; 1981 Sep; 98(6):627-41. PubMed ID: 7026144
    [No Abstract]   [Full Text] [Related]  

  • 69. Beta-adrenergic blocking therapy in hypertension: selection of patients.
    Frohlich ED; Tarazi RC; Dustan HP
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):151-6. PubMed ID: 4395481
    [No Abstract]   [Full Text] [Related]  

  • 70. Pharmacodynamics and pharmacokinetics of xipamide in patients with normal and impaired kidney function.
    Knauf H; Mutschler E
    Eur J Clin Pharmacol; 1984; 26(4):513-20. PubMed ID: 6734710
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Clinical results of the combined use of a diuretic and a beta-blocking agent in the therapy of arterial hypertension].
    Allegri M; Magni S; Freggiaro V; Stirace T
    Clin Ter; 1982 Jan; 100(1):11-9. PubMed ID: 7151366
    [No Abstract]   [Full Text] [Related]  

  • 72. Treatment of essential hypertension. A comparison between nadolol, once daily, and propranolol, four times daily.
    Frithz G
    Practitioner; 1982 Mar; 226(1365):562-4. PubMed ID: 7045847
    [No Abstract]   [Full Text] [Related]  

  • 73. [Comparative double-blind, randomized, crossover study controlled with placebo, of the efficacy of depot nifedipine in patients refractory to basic antihypertensive therapy].
    Bozza AE; Guimarães FJ; de Carvalho FJ; Santos LC; Pellon FM; de Castro RF; Balbuena RR
    Arq Bras Cardiol; 1984 Sep; 43(3):213-7. PubMed ID: 6398994
    [No Abstract]   [Full Text] [Related]  

  • 74. [Cardiovascular effects of acute administration of labetalol in hypertensive patients].
    Novo S; Pinto A; Davì G; Riolo F; Gullotti D
    Boll Soc Ital Cardiol; 1980; 25(2):149-56. PubMed ID: 7016144
    [No Abstract]   [Full Text] [Related]  

  • 75. [Protection of the hypertensive patient: comparative study of atenolol and metoprolol].
    Mazzari M; Coppola E; Montenero AS; Schiavoni G; Domenichelli B; Mongiardo R; Pennestrì F
    Cardiologia; 1982; 27(8):753-63. PubMed ID: 6765444
    [No Abstract]   [Full Text] [Related]  

  • 76. International multicentre study of indapamide in the treatment of essential arterial hypertension.
    Passeron J; Pauly N; Desprat J
    Postgrad Med J; 1981; 57 Suppl 2():57-9. PubMed ID: 7033949
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Effect of 3 hypertensive++ agents on ventricular geometry and function].
    Gómez Pajuelo C; Gómez Sánchez MA; Marín Ruiz R; Lombera Romero F; Sanz Julve M; Tascón Pérez J; Sáenz de la Calzada C
    Med Clin (Barc); 1995 Mar; 104(9):334-8. PubMed ID: 7731301
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Practolol-propranolol. A comparison of antihypertensive effect.
    Andersson O; Berglund G
    Acta Med Scand; 1974 Dec; 196(6):479-82. PubMed ID: 4617491
    [No Abstract]   [Full Text] [Related]  

  • 79. [Saluretic treatment of hypertension and uric acid level in serum. Clinical test of a combination of hydrochlorothiazide and probenecid].
    Kusus T; Lydtin H; Zöllner N
    Arzneimittelforschung; 1969 Nov; 19(11):1887-9. PubMed ID: 4905289
    [No Abstract]   [Full Text] [Related]  

  • 80. Comparison of the hypotensive effects of bendrofluazide, bumetanide and xipamide.
    Gabriel R
    Curr Med Res Opin; 1983; 8(9):645-8. PubMed ID: 6667628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.